These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9190664)

  • 1. [Community-acquired pneumonia: considerations on ambulatory management].
    Zanetti G
    Schweiz Med Wochenschr; 1997 Mar; 127(13):528-34. PubMed ID: 9190664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired pneumonia.
    Lynch JP; Martinez FJ
    Curr Opin Pulm Med; 1998 May; 4(3):162-72. PubMed ID: 9675519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood community-acquired pneumonia.
    Ruuskanen O; Mertsola J
    Semin Respir Infect; 1999 Jun; 14(2):163-72. PubMed ID: 10391410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pneumonia in clinical practice: diagnosis and therapy].
    Zimmerli W
    Praxis (Bern 1994); 1994 Dec; 83(49):1374-7. PubMed ID: 7801011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
    Isozumi R; Yoshimine H; Morozumi M; Ubukata K; Ariyoshi K
    Respirology; 2009 Nov; 14(8):1206-8. PubMed ID: 19732389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices.
    Bartlett JG
    Semin Respir Infect; 1997 Dec; 12(4):329-33. PubMed ID: 9436960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What is new in the treatment of community-acquired pneumonia?].
    Welte T; Marre R; Suttorp N;
    Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An emergency department-based randomized trial of nonbronchoscopic bronchoalveolar lavage for early pathogen identification in severe community-acquired pneumonia.
    Rodriguez RM; Fancher ML; Phelps M; Hawkins K; Johnson J; Stacks K; Rossini T; Way M; Holland D
    Ann Emerg Med; 2001 Oct; 38(4):357-63. PubMed ID: 11574790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired pneumonia in the elderly.
    Torres A; El-Ebiary M; Riquelme R; Ruiz M; Celis R
    Semin Respir Infect; 1999 Jun; 14(2):173-83. PubMed ID: 10391411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
    Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
    Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of atypical pathogens of community-acquired pneumonia.
    Plouffe JF
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S35-9. PubMed ID: 10984326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microbiological diagnosis of community-acquired pneumopathies].
    Péan Y
    Med Mal Infect; 2011 Jan; 41(1 Suppl 1):H2-4. PubMed ID: 21335251
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe community-acquired pneumonia: an Australian perspective.
    Wilson PA; Ferguson J
    Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pneumonia in ambulatory care patients. Choice of antibiotics for therapy of community-acquired pneumonia].
    Buchenroth M; Lorenz J
    Fortschr Med; 1998 Apr; 116(11):22-8, 30. PubMed ID: 9609921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia.
    Ortega L; Sierra M; Domínguez J; Martínez J; Matas L; Bastart F; Galí N; Ausina V
    Scand J Infect Dis; 2005; 37(9):657-63. PubMed ID: 16126566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired pneumonia in infants and children.
    Ostapchuk M; Roberts DM; Haddy R
    Am Fam Physician; 2004 Sep; 70(5):899-908. PubMed ID: 15368729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Community acquired pneumonia].
    Marrie TJ
    Praxis (Bern 1994); 2001 May; 90(21):935-40. PubMed ID: 11512537
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis and ambulatory treatment of patients with community-acquired pneumonia: variability of complementary tests and study of the effectiveness of roxithromycin. Study Group on Ambulatory Treatment of Community-Acquired Pneumonia (NACTA)].
    Rev Clin Esp; 1999 Nov; 199(11):700-4. PubMed ID: 10638232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.